Analysis of Vpr Genetic Variations between Chinese Major Circulating Recombinants CRF01_AE and CRF07_BC

Author(s): Ling Du, Lina Wang, Tong Yu, Ruolei Xin*, Zhefeng Meng*

Journal Name: Current HIV Research

Volume 18 , Issue 3 , 2020


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: HIV-1 CRF01_AE and CRF07_BC recombinant strains are responsible for more than 80% of new infections in China since the beginning of the 2000s. These two strains may have distinct genetic mutations, which resulted in distinct patterns of pathogenesis related to the viral gene, Vpr.

Objective: The amino acid pattern and genetic diversity of Vpr were analyzed and characterized in HIV-1 CRF01_AE and CRF07_BC HIV-1 strains.

Methods: The Vpr gene was amplified from extracted viral RNA and DNA sequencing was performed using an ABI3730 analyzer. The positional amino acid composition, genetic variation and distance of Vpr sequence were analyzed by Bio-Edit 7.2 and Mega 6.01 software packages.

Results: A total of 162 CRF01_AE and 80 CRF07_BC derived Vpr sequences were obtained by DNA sequencing. CRF01_AE patients showed higher viral load and lower CD4 counts than CRF07_BC patients (P<0.05). Higher genetic distance and more polymorphic amino acids were found in CRF01_AE Vpr than CRF07_BC Vpr (P<0.05). The common conservative amino acid region was identified as 29EAVRHFP35 in both CRF07_BC and CRF01_AE. Of note, the R77Q mutation was found in both the most recently Chinese derived CRF07_BC and CRF01_AE Vpr.

Conclusion: CRF01_AE derived Vpr has higher genetic variation and pathogenesis in comparison to the CRF07_BC strain.

Keywords: HIV-1, CRF01_AE, CRF07_BC, Vpr, genetic, variation.

[1]
Tang Q, Lu H. HIV/AIDS responses in China should focus on the impact of global integration. Biosci Trends 2018; 12(5): 507-9.
[http://dx.doi.org/10.5582/bst.2018.01269] [PMID: 30473559]
[2]
Burki T. HIV in China: a changing epidemic. Lancet Infect Dis 2018; 18(12): 1311-2.
[http://dx.doi.org/10.1016/S1473-3099(18)30680-7] [PMID: 30507454]
[3]
Ritchwood TD, He J, Smith MK, et al. “Getting to zero” among men who have sex with men in China: A review of the HIV care continuum. Curr HIV/AIDS Rep 2019; 16(6): 431-8.
[http://dx.doi.org/10.1007/s11904-019-00472-3] [PMID: 31792704]
[4]
He N, Ding Y, Li J, et al. HIV and Aging in Mainland China: Implications for Control and Prevention Research. Curr HIV/AIDS Rep 2019; 16(6): 439-47.
[http://dx.doi.org/10.1007/s11904-019-00473-2] [PMID: 31773404]
[5]
Ding Y, Ma Z, He J, et al. Evolving HIV Epidemiology in Mainland China: 2009-2018. Curr HIV/AIDS Rep 2019; 16(6): 423-30.
[http://dx.doi.org/10.1007/s11904-019-00468-z] [PMID: 31773403]
[6]
Wang Y, De Clercq E, Li G. Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment. Expert Opin Drug Metab Toxicol 2019; 15(10): 813-29.
[http://dx.doi.org/10.1080/17425255.2019.1673367] [PMID: 31556749]
[7]
Liu Z, Shi O, Yan Q, et al. Changing epidemiological patterns of HIV and AIDS in China in the post-SARS era identified by the nationwide surveillance system. BMC Infect Dis 2018; 18(1): 700.
[http://dx.doi.org/10.1186/s12879-018-3551-5] [PMID: 30587142]
[8]
Lou J, Cheng J, Li Y, et al. Comparison of different strategies for controlling HIV/AIDS spreading in MSM. Infect Dis Model 2018; 3: 293-300.
[http://dx.doi.org/10.1016/j.idm.2018.10.002] [PMID: 30839918]
[9]
Yuan R, Cheng H, Chen LS, Zhang X, Wang B. Prevalence of different HIV-1 subtypes in sexual transmission in China: a systematic review and meta-analysis. Epidemiol Infect 2016; 144(10): 2144-53.
[http://dx.doi.org/10.1017/S0950268816000212] [PMID: 26892485]
[10]
Phanuphak N, Lo YR, Shao Y, et al. HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials. AIDS Res Hum Retroviruses 2015; 31(11): 1060-76.
[http://dx.doi.org/10.1089/aid.2015.0049] [PMID: 26107771]
[11]
Zhang L, Wang YJ, Wang BX, Yan JW, Wan YN, Wang J. Prevalence of HIV-1 subtypes among men who have sex with men in China: a systematic review. Int J STD AIDS 2015; 26(5): 291-305.
[http://dx.doi.org/10.1177/0956462414543841] [PMID: 25033880]
[12]
Xiao P, Li J, Fu G, Zhou Y, Huan X, Yang H. Geographic Distribution and Temporal Trends of HIV-1 Subtypes through Heterosexual Transmission in China: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2017; 14(7) E830
[http://dx.doi.org/10.3390/ijerph14070830] [PMID: 28737729]
[13]
He X, Xing H, Ruan Y, et al. A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey. PLoS One 2012; 7(10) e47289
[http://dx.doi.org/10.1371/journal.pone.0047289] [PMID: 23056619]
[14]
Feng Y, He X, Hsi JH, et al. The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s. AIDS 2013; 27(11): 1793-802.
[http://dx.doi.org/10.1097/QAD.0b013e328360db2d] [PMID: 23807275]
[15]
Abubakar YF, Meng Z, Zhang X, Xu J. Multiple independent introductions of HIV-1 CRF01_AE identified in China: what are the implications for prevention? PLoS One 2013; 8(11) e80487
[http://dx.doi.org/10.1371/journal.pone.0080487] [PMID: 24282546]
[16]
Yin Y, Liu Y, Zhu J, et al. The prevalence, temporal trends, and geographical distribution of HIV-1 subtypes among men who have sex with men in China: A systematic review and meta-analysis. Epidemiol Infect 2019; 147 e83
[http://dx.doi.org/10.1017/S0950268818003400] [PMID: 30869019]
[17]
Wang W, Xu J, Jiang S, et al. The dynamic face of HIV-1 subtypes among men who have sex with men in Beijing, China. Curr HIV Res 2011; 9(2): 136-9.
[http://dx.doi.org/10.2174/157016211795569096] [PMID: 21361866]
[18]
Wang W, Meng Z, Zhou M, et al. Near full-length sequence analysis of two new HIV type 1 unique (CRF01_AE/B) recombinant forms among men who have sex with men in China. AIDS Res Hum Retroviruses 2012; 28(4): 411-7.
[http://dx.doi.org/10.1089/aid.2011.0196] [PMID: 21902589]
[19]
Nikolopoulos GK, Kostaki EG, Paraskevis D. Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia. Infect Genet Evol 2016; 46: 256-68.
[http://dx.doi.org/10.1016/j.meegid.2016.06.017] [PMID: 27287560]
[20]
Han X, An M, Zhang W, et al. Genome sequences of a novel HIV-1 circulating recombinant form, CRF55_01B, identified in China. Genome Announc 2013; 1(1): e00050-12.
[http://dx.doi.org/10.1128/genomeA.00050-12] [PMID: 23405298]
[21]
Feng Y, Wei H, Hsi J, et al. Identification of a novel HIV Type 1 circulating recombinant form (CRF65_cpx) composed of CRF01_AE and subtypes B and C in Western Yunnan, China. AIDS Res Hum Retroviruses 2014; 30(6): 598-602.
[http://dx.doi.org/10.1089/aid.2013.0233] [PMID: 24279591]
[22]
Jia L, Gui T, Li L, et al. A considerable proportion of CRF01_AE strains in China originated from circulating intrasubtype recombinant forms (CIRF). BMC Infect Dis 2015; 15: 528.
[http://dx.doi.org/10.1186/s12879-015-1273-5] [PMID: 26572485]
[23]
Huang X, Yu G, Zhou P, et al. Near full-length genomic sequence analysis of an HIV-1 01_AE/07_BC unique recombinant form virus. China Trop Med 2016; 16: 1064-9.
[24]
Wu J, Meng Z, Xu J, et al. New emerging recombinant HIV-1 strains and close transmission linkage of HIV-1 strains in the Chinese MSM population indicate a new epidemic risk. PLoS One 2013; 8(1) e54322
[http://dx.doi.org/10.1371/journal.pone.0054322] [PMID: 23372706]
[25]
Meng Z, Xin R, Zhong P, et al. A new migration map of HIV-1 CRF07_BC in China: analysis of sequences from 12 provinces over a decade. PLoS One 2012; 7(12) e52373
[http://dx.doi.org/10.1371/journal.pone.0052373] [PMID: 23300654]
[26]
Cheng H, Zhang J, Capizzi J, Young NL, Mastro TD. HIV-1 subtype E in Yunnan, China. Lancet 1994; 344(8927): 953-4.
[http://dx.doi.org/10.1016/S0140-6736(94)92304-3] [PMID: 7934363]
[27]
Rhee SY, Shafer RW. Geographically-stratified HIV-1 group M pol subtype and circulating recombinant form sequences. Sci Data 2018; 5 180148
[http://dx.doi.org/10.1038/sdata.2018.148] [PMID: 30063225]
[28]
Sauter D, Kirchhoff F. Multilayered and versatile inhibition of cellular antiviral factors by HIV and SIV accessory proteins. Cytokine Growth Factor Rev 2018; 40: 3-12.
[http://dx.doi.org/10.1016/j.cytogfr.2018.02.005] [PMID: 29526437]
[29]
Fabryova H, Strebel K. Vpr and its cellular interaction partners: R we there yet? Cells 2019; 8(11) E1310
[http://dx.doi.org/10.3390/cells8111310] [PMID: 31652959]
[30]
Nodder SB, Gummuluru S. Illuminating the role of Vpr in HIV infection of myeloid cells. Front Immunol 2019; 10: 1606.
[http://dx.doi.org/10.3389/fimmu.2019.01606] [PMID: 31396206]
[31]
Chougui G, Margottin-Goguet F. HUSH, a Link Between Intrinsic Immunity and HIV Latency. Front Microbiol 2019; 10: 224.
[http://dx.doi.org/10.3389/fmicb.2019.00224] [PMID: 30809215]
[32]
Sumner RP, Thorne LG, Fink DL, Khan H, Milne RS, Towers GJ. Are Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission? Front Immunol 2017; 8: 1246.
[http://dx.doi.org/10.3389/fimmu.2017.01246] [PMID: 29056936]
[33]
Faust TB, Binning JM, Gross JD, Frankel AD. Making sense of multifunctional proteins: Human immunodeficiency virus type 1 accessory and regulatory proteins and connections to transcription. Annu Rev Virol 2017; 4(1): 241-60.
[http://dx.doi.org/10.1146/annurev-virology-101416-041654] [PMID: 28961413]
[34]
Win NN, Ngwe H, Abe I, Morita H. Naturally occurring Vpr inhibitors from medicinal plants of Myanmar. J Nat Med 2017; 71(4): 579-89.
[http://dx.doi.org/10.1007/s11418-017-1104-7] [PMID: 28681118]
[35]
Herrmann A, Happel AU, Gramberg T. SAMHD1 in Retroviral Restriction and Innate Immune Sensing--Should We Leash the Hound? Curr HIV Res 2016; 14(3): 225-34.
[http://dx.doi.org/10.2174/1570162X14999160224102515] [PMID: 26957197]
[36]
D Urbano V, De Crignis E, Re MC. Host restriction factors and human immunodeficiency virus (HIV-1): A dynamic interplay involving all phases of the viral life cycle. Curr HIV Res 2018; 16(3): 184-207.
[http://dx.doi.org/10.2174/1570162X16666180817115830] [PMID: 30117396]
[37]
Council OD, Joseph SB. Evolution of host target cell specificity during HIV-1 infection. Curr HIV Res 2018; 16(1): 13-20.
[http://dx.doi.org/10.2174/1570162X16666171222105721] [PMID: 29268687]
[38]
Guenzel CA, Hérate C, Benichou S. HIV-1 Vpr-a still “enigmatic multitasker”. Front Microbiol 2014; 5: 127.
[http://dx.doi.org/10.3389/fmicb.2014.00127] [PMID: 24744753]
[39]
Kamori D, Hasan Z, Ohashi J, et al. Identification of two unique naturally occurring Vpr sequence polymorphisms associated with clinical parameters in HIV-1 chronic infection. J Med Virol 2017; 89(1): 123-9.
[http://dx.doi.org/10.1002/jmv.24612] [PMID: 27328918]
[40]
Morellet N, Bouaziz S, Petitjean P, Roques BP. NMR structure of the HIV-1 regulatory protein VPR. J Mol Biol 2003; 327(1): 215-27.
[http://dx.doi.org/10.1016/S0022-2836(03)00060-3] [PMID: 12614620]
[41]
Godet AN, Guergnon J, Croset A, et al. PP2A1 binding, cell transducing and apoptotic properties of Vpr(77-92): a new functional domain of HIV-1 Vpr proteins. PLoS One 2010; 5(11) e13760
[http://dx.doi.org/10.1371/journal.pone.0013760] [PMID: 21072166]
[42]
Tungaturthi PK, Sawaya BE, Ayyavoo V, Murali R, Srinivasan A. HIV-1 Vpr: genetic diversity and functional features from the perspective of structure. DNA Cell Biol 2004; 23(4): 207-22.
[http://dx.doi.org/10.1089/104454904773819798] [PMID: 15142378]
[43]
Hadi K, Walker LA, Guha D, et al. Human immunodeficiency virus type 1 Vpr polymorphisms associated with progressor and nonprogressor individuals alter Vpr-associated functions. J Gen Virol 2014; 95(Pt 3): 700-11.
[http://dx.doi.org/10.1099/vir.0.059576-0] [PMID: 24300552]
[44]
Soares R, Rocha G, Meliço-Silvestre A, Gonçalves T. HIV1-viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies. Rev Med Virol 2016; 26(5): 314-29.
[http://dx.doi.org/10.1002/rmv.1889] [PMID: 27264019]
[45]
Somasundaran M, Sharkey M, Brichacek B, et al. Evidence for a cytopathogenicity determinant in HIV-1 Vpr. Proc Natl Acad Sci USA 2002; 99(14): 9503-8.
[http://dx.doi.org/10.1073/pnas.142313699] [PMID: 12093916]
[46]
Xin RL, Feng Y, Cheng CL, et al. [Primers of gag gene for HIV-1 subtyping in China and application thereof in practice]. Zhonghua Yi Xue Za Zhi 2009; 89(13): 876-80.
[PMID: 19671285]
[47]
Rajan D, Wildum S, Rücker E, Schindler M, Kirchhoff F. Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo. AIDS 2006; 20(6): 831-6.
[http://dx.doi.org/10.1097/01.aids.0000218546.31716.7f] [PMID: 16549966]
[48]
Zhao J, Cai W, Zheng C, et al. Origin and outbreak of HIV-1 CRF55_01B among MSM in Shenzhen, China. J Acquir Immune Defic Syndr 2014; 66(3): e65-7.
[http://dx.doi.org/10.1097/QAI.0000000000000144] [PMID: 24662297]
[49]
Li Y, Han Y, Xie J, et al. CRF01_AE subtype is associated with X4 tropism and fast HIV progression in Chinese patients infected through sexual transmission. AIDS 2014; 28(4): 521-30.
[http://dx.doi.org/10.1097/QAD.0000000000000125] [PMID: 24472744]
[50]
Li X, Xue Y, Zhou L, et al. Evidence that HIV-1 CRF01_AE is associated with low CD4+T cell count and CXCR4 co-receptor usage in recently infected young men who have sex with men (MSM) in Shanghai, China. PLoS One 2014; 9(2) e89462
[http://dx.doi.org/10.1371/journal.pone.0089462] [PMID: 24586795]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 18
ISSUE: 3
Year: 2020
Published on: 11 June, 2020
Page: [165 - 171]
Pages: 7
DOI: 10.2174/1570162X18666200225113857
Price: $65

Article Metrics

PDF: 11
HTML: 4